Beta

Beta measures a stock's sensitivity to market movements, quantifying how much the stock's price tends to fluctuate relative to a benchmark index (typically the S&P 500 or a relevant market index). It is a cornerstone of modern portfolio theory and the Capital Asset Pricing Model (CAPM), used to assess systematic risk—the portion of a stock's volatility tied to overall market conditions.

The calculation involves regression analysis comparing the stock's returns against the market's returns over a historical period, typically 2-5 years of monthly data:

Beta = Covariance(Stock Returns, Market Returns) / Variance(Market Returns)

Interpreting beta values:

• Beta = 1.0: The stock moves in line with the market. A 1% market move corresponds to approximately a 1% stock move
• Beta > 1.0: Higher volatility than the market. A beta of 1.5 suggests the stock moves 1.5% for every 1% market move
• Beta < 1.0: Lower volatility than the market. A beta of 0.5 implies roughly half the market's movement
• Beta < 0: Rare; indicates the stock tends to move opposite to the market (gold stocks sometimes exhibit this)

For example, if the market rises 10% and a stock with beta 1.3 rises 13%, this aligns with expectations. In a 10% market decline, you'd expect roughly a 13% drop in that stock. This asymmetry makes high-beta stocks attractive in bull markets but dangerous in downturns.

Beta has several important limitations:

• Historical measure: Past beta may not predict future volatility, especially if the company's business has changed
• Time-period sensitive: Different calculation windows can produce significantly different betas
• Ignores unsystematic risk: Company-specific risks like management changes or product failures are not captured
• Assumes linear relationships: Actual stock behaviour may be more complex, especially during market stress

Investors use beta to construct portfolios matching their risk tolerance. Conservative investors often prefer low-beta stocks (utilities, consumer staples), while aggressive investors may seek high-beta names (technology, biotech). However, beta should be one factor among many—a low-beta stock with deteriorating fundamentals may be riskier than its beta suggests.